Target intelligence / Profile preview

Mitochondrial oxidative phosphorylation system and associated phospholipids (OXPHOS)

Target
OXPHOS
Molecular classification
Enzyme, Other
01

Overview

The mitochondrial oxidative phosphorylation (OXPHOS) system, integrated with its essential phospholipid environment (notably cardiolipin), is the primary site of cellular energy production via ATP synthesis (Paradies et al., 2019, PMID: 31100344). This system consists of five multi-subunit protein complexes (I-V) embedded in the inner mitochondrial membrane, where phospholipids provide the structural scaffold and functional support necessary for electron transfer and proton gradient maintenance (Mejia and Hatch, 2016, PMID: 26703187). Cardiolipin, a unique dimeric phospholipid, is particularly critical as it anchors the respiratory complexes into "supercomplexes" to enhance efficiency and minimize reactive oxygen species (ROS) leakage (Szeto, 2014, PMID: 24102316). Dysregulation of this system, often involving cardiolipin peroxidation or complex mutations, is a hallmark of mitochondrial myopathies, heart failure, and neurodegenerative disorders (Chinnery, 2015, PMID: 25582790). Therapeutic strategies targeting this system include small molecules like elamipretide, which binds to cardiolipin to stabilize the membrane-protein interface and restore bioenergetics (Szeto, 2014, PMID: 24102316). However, because OXPHOS is fundamental to almost all cell types, pharmacological intervention carries risks of systemic toxicity and metabolic disruption such as lactic acidosis (Owen et al., 2000, PMID: 10839993).

Other names
Mitochondrial respiratory chainOXPHOSCardiolipin-respiratory complexInner mitochondrial membrane bioenergetic system
02

Mechanism of action

Stabilization of the inner mitochondrial membrane and respiratory supercomplexes through lipid-protein interactions, or direct modulation of electron transport chain complex activity.

03

Biological functions

ApoptosisCell deathOther
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

Lactic acidosisSystemic metabolic toxicityInhibition of essential cellular respirationNarrow therapeutic index
06

Interacting drugs

Elamipretide

6 more in the full profile.

07

Biomarkers

Oxygen consumption rate (OCR)Lactate-to-pyruvate ratioCardiolipin oxidation levelsATP production rate

Beyond the preview

Go deeper on Mitochondrial oxidative phosphorylation system and associated phospholipids (OXPHOS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial oxidative phosphorylation system and associated phospholipids (OXPHOS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call